niclosamide has been researched along with Carcinoma, Small Cell Lung in 2 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hochmair, M | 1 |
| Rath, B | 1 |
| Klameth, L | 1 |
| Ulsperger, E | 1 |
| Weinlinger, C | 1 |
| Fazekas, A | 1 |
| Plangger, A | 1 |
| Zeillinger, R | 1 |
| Hamilton, G | 1 |
| He, X | 1 |
| Li, M | 1 |
| Ye, W | 1 |
| Zhou, W | 1 |
2 other studies available for niclosamide and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.
Topics: Antigens, CD; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Humans; Lung Neop | 2020 |
Discovery of degradable niclosamide derivatives able to specially inhibit small cell lung cancer (SCLC).
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Drug | 2021 |